Bruno Catalanotti

1.9k total citations
59 papers, 1.4k citations indexed

About

Bruno Catalanotti is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Bruno Catalanotti has authored 59 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Pharmacology. Recurrent topics in Bruno Catalanotti's work include DNA and Nucleic Acid Chemistry (12 papers), Drug Transport and Resistance Mechanisms (10 papers) and RNA Interference and Gene Delivery (8 papers). Bruno Catalanotti is often cited by papers focused on DNA and Nucleic Acid Chemistry (12 papers), Drug Transport and Resistance Mechanisms (10 papers) and RNA Interference and Gene Delivery (8 papers). Bruno Catalanotti collaborates with scholars based in Italy, Switzerland and Sweden. Bruno Catalanotti's co-authors include Caterina Fattorusso, Giuseppe Campiani, Ettore Novellino, Vito Nacci, Stefania Butini, Sandra Gemma, Ashima Saxena, Anna Ramunno, Luisa Savini and Marco Persico and has published in prestigious journals such as Nature Communications, Gastroenterology and PLoS ONE.

In The Last Decade

Bruno Catalanotti

57 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruno Catalanotti Italy 21 573 415 336 292 198 59 1.4k
Rajani Giridhar India 26 542 0.9× 782 1.9× 276 0.8× 300 1.0× 88 0.4× 97 1.6k
Vito Nacci Italy 27 759 1.3× 814 2.0× 216 0.6× 191 0.7× 249 1.3× 48 1.6k
Brian Springthorpe United Kingdom 5 879 1.5× 546 1.3× 179 0.5× 589 2.0× 89 0.4× 8 1.8k
Gilbert M. Rishton United States 15 754 1.3× 323 0.8× 200 0.6× 450 1.5× 67 0.3× 17 1.5k
Christophe Rochais France 22 643 1.1× 561 1.4× 578 1.7× 551 1.9× 85 0.4× 70 1.8k
Ashutosh Tripathi United States 25 725 1.3× 298 0.7× 164 0.5× 198 0.7× 90 0.5× 73 1.7k
Antonio Carrieri Italy 25 827 1.4× 744 1.8× 354 1.1× 284 1.0× 121 0.6× 99 1.8k
Adel Hamza United States 23 1.2k 2.1× 292 0.7× 316 0.9× 357 1.2× 60 0.3× 60 2.1k
Paola Fossa Italy 30 1.2k 2.1× 1.2k 2.8× 328 1.0× 242 0.8× 102 0.5× 136 2.6k
Richard Morphy United Kingdom 12 1.3k 2.3× 932 2.2× 623 1.9× 804 2.8× 117 0.6× 16 2.6k

Countries citing papers authored by Bruno Catalanotti

Since Specialization
Citations

This map shows the geographic impact of Bruno Catalanotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Catalanotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Catalanotti more than expected).

Fields of papers citing papers by Bruno Catalanotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Catalanotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Catalanotti. The network helps show where Bruno Catalanotti may publish in the future.

Co-authorship network of co-authors of Bruno Catalanotti

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Catalanotti. A scholar is included among the top collaborators of Bruno Catalanotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Catalanotti. Bruno Catalanotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Finamore, Claudia, Carmen Festa, Marcella Cammarota, et al.. (2025). Exploring Boswellia serrata Triterpenes: A New Frontier in Leukemia Inhibitory Factor Receptor Modulation. ACS Omega. 10(21). 22269–22284. 2 indexed citations
2.
Moraca, Federica, Elva Morretta, Cristina Di Giorgio, et al.. (2025). Harnessing the Estradienone Scaffold to Develop Dual GPBAR1 and LIFR Modulators for Liver Fibrosis. Journal of Medicinal Chemistry. 68(19). 20037–20059.
3.
Finamore, Claudia, Cristina Di Giorgio, Silvia Marchianò, et al.. (2024). Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis. Journal of Medicinal Chemistry. 67(20). 18334–18355. 6 indexed citations
4.
Roselli, Rosalinda, Claudia Finamore, Michele Biagioli, et al.. (2023). Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders. ACS Omega. 8(6). 5983–5994. 5 indexed citations
5.
Donne, Rossella Delle, Laura Rinaldi, Federica Moraca, et al.. (2023). Ubiquitylation of BBSome is required for ciliary assembly and signaling. EMBO Reports. 24(4). e55571–e55571. 10 indexed citations
6.
Ambrosio, Francesca Alessandra, Antonio Lupia, Federica Moraca, et al.. (2023). Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients. Pharmaceuticals. 16(8). 1143–1143. 2 indexed citations
7.
Lupia, Antonio, Alessandro Deplano, Luciano Pirone, et al.. (2022). Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition. International Journal of Molecular Sciences. 23(24). 15502–15502. 4 indexed citations
8.
Moraca, Federica, Francesco D’Amico, Antonio Lupia, et al.. (2022). Ligand-based drug repurposing strategy identified SARS-CoV-2 RNA G-quadruplex binders. Chemical Communications. 58(85). 11913–11916. 13 indexed citations
9.
Biagioli, Michele, Silvia Marchianò, Rosalinda Roselli, et al.. (2022). GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation. Cells. 11(7). 1187–1187. 16 indexed citations
10.
Giorgio, Cristina Di, Antonio Lupia, Silvia Marchianò, et al.. (2022). Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma. Cells. 11(21). 3482–3482. 9 indexed citations
11.
Fiorucci, Stefano, Rosalinda Roselli, Silvia Marchianò, et al.. (2022). Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease. Frontiers in Pharmacology. 13. 858137–858137. 6 indexed citations
12.
Deplano, Alessandro, Jessica Karlsson, Federica Moraca, et al.. (2021). Design, synthesis and in vitro and in vivo biological evaluation of flurbiprofen amides as new fatty acid amide hydrolase/cyclooxygenase-2 dual inhibitory potential analgesic agents. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 940–953. 5 indexed citations
13.
Deplano, Alessandro, Jessica Karlsson, Mona Svensson, et al.. (2020). Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen. Journal of Enzyme Inhibition and Medicinal Chemistry. 35(1). 815–823. 14 indexed citations
14.
Deplano, Alessandro, Mariateresa Cipriano, Federica Moraca, et al.. (2019). Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 34(1). 562–576. 11 indexed citations
15.
Catalano, Raffaella, Federica Moraca, Jussara Amato, et al.. (2019). Targeting multiple G-quadruplex–forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives. European Journal of Medicinal Chemistry. 182. 111627–111627. 19 indexed citations
16.
Deplano, Alessandro, Monica Demurtas, Emmelie Björklund, et al.. (2017). Novel propanamides as fatty acid amide hydrolase inhibitors. European Journal of Medicinal Chemistry. 136. 523–542. 10 indexed citations
17.
Karlsson, Jessica, Alessandro Deplano, Giovanni Smaldone, et al.. (2015). Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode. PLoS ONE. 10(11). e0142711–e0142711. 12 indexed citations
18.
Budriesi, Roberta, Pierfranco Ioan, Alberto Chiarini, et al.. (2004). Development of Potent and Selective Peripheral 5-HT3 Receptor Agonists and Antagonists, Keystones of a New Therapeutic Strategy to Cardiac Diseases. Fundamental and Clinical Pharmacology. 18. 138–138. 1 indexed citations
19.
Campiani, Giuseppe, Anna Ramunno, Giovanni Maga, et al.. (2002). Non-Nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors: Past, Present, and Future Perspectives. Current Pharmaceutical Design. 8(8). 615–657. 101 indexed citations
20.
Catalanotti, Bruno, Aldo Galeone, Luciano Mayol, Antonella Pepe, & Virginia Lanzotti. (1997). SYNTHETIC POLYNUCLEOTIDES AND ANALOGUES AS MODELS FOR STUDIES CONCERNING DNA. Gazzetta chimica italiana. 127(5). 231–246.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026